Wells Fargo & Company Gsk PLC Put Options Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $4,205 - $4,777	-100 Reduced 0.39%	25,700 $1.12 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $16.6 Million - $19.7 Million	-411,700 Reduced 94.1%	25,800 $1.12 Million
Q1 2021 May 13, 2021	BUY	$34.27 - $40.01 $819,053 - $956,239	23,900 Added 5.78%	437,500 $15.6 Million
Q4 2020 Feb 09, 2021	BUY	$34.07 - $39.94 $265,746 - $311,532	7,800 Added 1.92%	413,600 $2.49 Million
Q3 2020 Nov 05, 2020	SELL	$38.11 - $42.99 $1.83 Million - $2.06 Million	-48,000 Reduced 10.58%	405,800 $2.47 Million
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $7.55 Million - $8.69 Million	199,400 Added 78.38%	453,800 $2.01 Million
Q1 2020 May 14, 2020	BUY	$32.47 - $48.83 $8.26 Million - $12.4 Million	254,400 New	254,400 $1.84 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.